Search

Your search keyword '"Fenwick, Craig"' showing total 257 results

Search Constraints

Start Over You searched for: Author "Fenwick, Craig" Remove constraint Author: "Fenwick, Craig"
257 results on '"Fenwick, Craig"'

Search Results

1. A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

2. A novel whole blood assay to quantify the release of T cell associated cytokines in response to Bordetella pertussis antigens

4. 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis.

5. Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID-19

6. Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys

8. Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys

10. Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures

13. Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis

14. Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19

15. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

16. 360. A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

17. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques

19. PERISCOPE: road towards effective control of pertussis

20. Lymph node dendritic cells harbor inducible replication-competent HIV despite years of suppressive ART

22. ACE2 mimetic antibody potently neutralizes all SARS-CoV-2 variants and fully protects in XBB.1.5 challenged monkeys

24. Persistent humoral immunity in children and adolescents throughout the COVID-19 pandemic (June 2020 to July 2022): a prospective school-based cohort study (Ciao Corona) in Switzerland

25. Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study

27. Ocrelizumab Impairs the Phenotype and Function of Memory CD8+T Cells

28. Persistence of Replication Competent HIV in Lymph Node Dendritic Cells Despite Years of Suppressive ART

30. The deficiency in Th2-like Tfh cells affects the maturation and quality of HIV-specific B cell response in viremic infection

33. Active PD-L1 incorporation within HIV virions functionally impairs T follicular helper cells

34. Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients

37. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort

40. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus

41. SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties

42. Heterogenous Cellular and Humoral Immune Trajectories after SARS-CoV-2 Infection: Compensatory Responses in a Population-Based Cohort

44. A highly potent antibody effective against SARS-CoV-2 variants of concern

46. A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma

48. SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study

49. Defining the mechanism of action in a novel class of anti-PD-1 antibodies

50. A highly potent antibody effective against SARS-CoV-2 variants of concern

Catalog

Books, media, physical & digital resources